STRATA Skin Sciences Stock Scheduled to Reverse Split on Friday, June 7th (NASDAQ:SSKN)

STRATA Skin Sciences, Inc. (NASDAQ:SSKN) shares are set to reverse split before the market opens on Friday, June 7th. The 1-10 reverse split was announced on Friday, June 7th. The number of shares owned by shareholders will be adjusted after the closing bell on Friday, June 7th.

STRATA Skin Sciences Stock Performance

NASDAQ SSKN opened at $0.39 on Friday. The company has a current ratio of 1.05, a quick ratio of 0.84 and a debt-to-equity ratio of 1.60. The firm has a market capitalization of $13.50 million, a price-to-earnings ratio of -1.17 and a beta of 1.53. The firm’s 50 day simple moving average is $0.45 and its 200 day simple moving average is $0.50. STRATA Skin Sciences has a 1 year low of $0.26 and a 1 year high of $1.08.

STRATA Skin Sciences (NASDAQ:SSKN) last posted its quarterly earnings results on Wednesday, May 15th. The medical device company reported ($0.10) earnings per share (EPS) for the quarter. The firm had revenue of $6.75 million for the quarter. STRATA Skin Sciences had a negative return on equity of 65.76% and a negative net margin of 34.92%. As a group, research analysts expect that STRATA Skin Sciences will post -0.27 earnings per share for the current fiscal year.

Institutional Trading of STRATA Skin Sciences

Large investors have recently made changes to their positions in the company. Azzad Asset Management Inc. ADV boosted its position in shares of STRATA Skin Sciences by 289.5% during the 1st quarter. Azzad Asset Management Inc. ADV now owns 67,000 shares of the medical device company’s stock worth $25,000 after acquiring an additional 49,800 shares in the last quarter. Chicago Partners Investment Group LLC lifted its stake in STRATA Skin Sciences by 162.0% in the 4th quarter. Chicago Partners Investment Group LLC now owns 64,223 shares of the medical device company’s stock valued at $33,000 after purchasing an additional 39,706 shares during the last quarter. Finally, 22NW LP lifted its stake in STRATA Skin Sciences by 56.1% in the 3rd quarter. 22NW LP now owns 5,369,954 shares of the medical device company’s stock valued at $3,195,000 after purchasing an additional 1,930,693 shares during the last quarter. Institutional investors and hedge funds own 32.43% of the company’s stock.

STRATA Skin Sciences Company Profile

STRATA Skin Sciences, Inc, a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment.